Skip to main content

Jacob S Sherkow


Additional Campus Affiliations

Professor, College of Law
Affiliate, Carl R. Woese Institute for Genomic Biology
Professor, Biomedical and Translational Sciences
Director, IP Law Program, College of Law

Recent Publications

Sherkow, J. S., Park, J. K., & Lu, C. Y. (2024). Regulating Direct-to-Consumer Polygenic Risk Scores. Obstetrical and Gynecological Survey, 79(2), 81-83.

Sherkow, J. S., Cook-Deegan, R., & Greely, H. T. (2024). The Myriad Decision at 10. Annual Review of Genomics and Human Genetics, 25. Advance online publication.

Lemley, M. A., & Sherkow, J. S. (2023). The Antibody Patent Paradox. Yale Law Journal, 132(4), 994-1064.

Sachs, R., Ouellette, L. L., Price II, W. N., & Sherkow, J. S. (2023). Innovation Law and Covid-19: Promoting Incentives and Access for New Health Care Technologies. In I. G. Cohen, A. R. Gluck, K. L. Kraschel, & C. Shachar (Eds.), Covid-19 and the Law: Disruption, Impact and Legacy (pp. 225-236). Cambridge University Press.

Sherkow, J. S., Adashi, E. Y., & Cohen, I. G. (2023). Assessing—and Extending—California’s Insulin Manufacturing Initiative. JAMA - Journal of the American Medical Association, 329(7), 533-534.

View all publications on Illinois Experts